Lilly Announces Global Restructuring

Posted: Updated:
Lilly says it expects the majority of eliminated positions to come through a voluntary retirement program. Lilly says it expects the majority of eliminated positions to come through a voluntary retirement program.

Editor's Note: Read the story titled "New Indy-to-Paris Flight Big For Business" by clicking here.

INDIANAPOLIS - Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a global restructuring, including work force reductions expected to impact about 3,500 workers. The company expects the moves to lead to about $500 million in annual savings beginning next year. The pharmaceutical giant says the cuts will include site closures in Iowa, New Jersey and China. Chief Executive Officer David Ricks says the restructuring will allow the company to reduce costs and "invest in the next generation of new medicines."

Lilly says it expects the majority of eliminated positions to come through a voluntary retirement program in the U.S., with those participating receiving enhanced retirement benefits. The company plans for that program to be largely completed by the end of the year.

As part of the restructuring, the company plans to move production from an animal health manufacturing facility in Larchwood, Iowa to an existing plant in Fort Dodge, Iowa. Lilly also says it will close a research and development office in Bridgewater, New Jersey and the Lilly China Research and Development Center in Shanghai, China.

Moving forward, the company says it will continue to evaluate the need to further reduce costs and improve efficiencies. It says those efforts could include additional work force adjustments.

"The commitment and perseverance of our people, who never give up on our mission of tackling hard-to-treat diseases, make up our legacy of more than 140 years," says Ricks. "We will implement changes with fairness and the utmost respect for our Lilly colleagues, while we remain a vibrant, thriving competitor."

Lilly expects to incur a charge of $1.2 billion through the effort, resulting in a reduced earnings per share guidance in 2017.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • Court Sides With Lilly on Alimta Case

      The latest in a string of patent infringement cases involving Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has ended positively for the pharmaceutical giant. The U.S. District Court for the Southern District of Indiana has ruled in favor of Lilly, preventing a competitor from launching an alternative form of its Alimta vitamin regimen. The court ruled that Lilly's patent for Alimta would be infringed upon if India-based Dr. Reddy's Laboratories had moved forward with...

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...

    • Auburn City Hardware Store Sold

      A historic northeast Indiana retailer is under new ownership. The KPC News reports the Auburn City Hardware Store has been sold to VRJ Holdings, which is also based in DeKalb County.